Omega-3 supplements may impact breast cancer riskDecember 13, 2021Metastatic Breast CancerBreast Cancer
Women struggle with benzodiazepine addiction post chemotherapy treatmentDecember 13, 2021Metastatic Breast CancerBreast Cancer
‘Surprising’ lack of benefit to adding palbociclib to endocrine therapy in early HR+/HER2– breast cancerDecember 13, 2021Metastatic Breast CancerBreast Cancer
Ongoing HER2 breast cancer therapy may cost an additional $68,000 per patientDecember 10, 2021Metastatic Breast CancerBreast Cancer
Vitamin D counters bone density loss with aromatase inhibitorsDecember 10, 2021Metastatic Breast CancerBreast Cancer
Metformin does not improve outcomes in early breast cancerDecember 10, 2021Metastatic Breast CancerBreast Cancer
Genomic profiling can improve PFS in metastatic breast cancerDecember 8, 2021Metastatic Breast CancerBreast Cancer
CDK4/6 inhibitors: Should they be stopped in the face of COVID-19?December 8, 2021Metastatic Breast Cancer
In metastatic breast cancer, primary resections on the declineDecember 8, 2021Metastatic Breast Cancer
Risk for breast cancer recurrence persists past 30 yearsNovember 18, 2021Metastatic Breast CancerBreast Cancer
